Endonovo Therapeutics Cash Flow Statement (2011-2023) | ENDV

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Dec2011	Mar2012	Jun2012	Sep2012	Dec2012	Mar2013	Jun2013	Sep2013	Dec2013	Mar2014	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023
Operating Activities
Net Income	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	0.00B	-0.00B	-0.01B	-0.00B	-0.01B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.01B	0.01B	0.00B	-0.00B
Depreciation and Depletion																	0.00B	0.00B			266.00	0.00B	0.00B	0.00B	747.00	851.00	903.00	904.00	0.00B	903.00	903.00	903.00	0.00B
Share-based Compensation	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	-26.00	0.00B	0.00B	0.00B	0.00B	0.00B			0.00B		0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B					0.00B	0.00B	0.00B	0.00B
Cash from Discontinued Operations													-0.00B	-0.00B			-193.84B	-426.06B
Gains from Investment Securities						532.00				532.00												0.09B								0.00B	0.00B						0.00B	0.00B
Asset Writedowns and Impairment				-0.00B					0.00B
Non-cash Items														0.00B				0.00B				0.09B								0.00B	0.00B						0.00B	0.00B
Cash from Operations	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B			-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles								-0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B					0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B
Depreciation & Amortization (CF)	0.00B	0.00B	0.00B	0.00B	143.00	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B			0.00B
Change in Working Capital
Change in Receivables		0.00B	364.00	-0.00B	0.00B		300.00	-300.00	300.00												0.00B	0.00B	-0.00B	695.00	0.00B	-0.00B	0.00B	0.00B	-0.00B	-0.00B	1.00		0.00B	0.00B	-0.00B	-0.00B					0.00B
Change in Inventory										-0.00B			0.00B	0.00B			0.00B	0.00B
Change in Account Payables	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B													0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B
Change in Accured Expenses										0.00B	-0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B			0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Other Working Capital Changes												0.00B	0.00B	0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B				0.00B			-0.00B	-0.00B	-0.00B	-0.00B	-760.00	0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.00B
Investing Activities
Capital Expenditures					-0.00B																0.00B						723.00
Acquisitions		0.00B					0.00B		-0.00B
Cash from Investing Activities		-0.00B			0.00B		-0.00B	0.00B	132.00												-0.00B						-723.00
Financing Activities
Other financing activities	0.00B				0.00B	0.00B	0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B			0.00B	0.00B
Cash from Financing Activities	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Dividend Payments
Dividends Paid - Preferred																												0.00B
Additional items
Change in Cash	0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	-930.00	0.00B	0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B			0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	0.00B	0.00B	-0.00B
Beginning Cash Balance									-0.00B	-0.00B											0.00B	0.00B					0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Free Cash Flow	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B			-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Net Cash Flow	0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B			0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B

Research Tools

Endonovo Therapeutics Cash Flow Statement (2011-2023) | ENDV

Create an account

Sign In

Reset Password